Paid Clinical Trials Victorville

Discover 571 paid clinical trials in Victorville, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 571

RetatrutideEffect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Apple Valley CA, Torrance CA, Canoga Park CA, Escondido CAshow 25 more

Code:

NCT06297603

Conditions

Type 2 Diabetes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Retatrutide

Placebo

RO7790121A Study to Assess the Efficacy and Safety of Induction Therapy With RO7790121 in Participants With Moderately to Severely Active Ulcerative Colitis

Recruiting

PHASE3

Sponsor:

Hoffmann-La Roche

Location:

Apple Valley CA, Lancaster CA, Garden Grove CA, Wichita KSshow 23 more

Code:

NCT06588855

Conditions

Moderately to Severely Active Ulcerative Colitis

Eligibility Criteria

Sex: All

Age: 16 - 70+

Healthy Volunteers: Not accepted

Interventions

RO7790121

Placebo

Tirzepatide & IxekizumabA Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

Recruiting

Sponsor:

Eli Lilly and Company

Location:

Apple Valley CA, Riverside CA, Covina CA, Whittier CAshow 29 more

Code:

NCT06864026

Conditions

Psoriatic Arthritis

Overweight or Obesity

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tirzepatide

DupilumabA Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis

Recruiting

PHASE2

PHASE3

Sponsor:

Regeneron Pharmaceuticals

Location:

Apple Valley CA, Lancaster CA, Los Angeles CA, Los Alamitos CAshow 35 more

Code:

NCT05831176

Conditions

Eosinophilic Gastritis

Eosinophilic Duodenitis

Eosinophilic Gastrointestinal Disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Dupilumab Dose 1

Dupilumab Dose 2

Matching Placebo

Glaucoma EvaluationGlaucoma Evaluation With the P200TE

Recruiting

Sponsor:

Optos, PLC

Location:

Cajon CA, Bellevue WA

Code:

NCT06305481

Conditions

Glaucoma

Eligibility Criteria

Sex: All

Age: 22+

Healthy Volunteers: Not accepted

Interventions

P200TE

Nail GenesisEvaluation of the Effectiveness of Nail Genesis DLSO Product for Onychomycosis

Recruiting

Sponsor:

Nail Genesis LLC

Location:

San Bernardino CA, Montclair CA, Sacramento CA, Austin TXshow 5 more

Code:

NCT06074315

Conditions

Distal Lateral Subungual Onychomycosis

Onychomycosis

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Nail Genesis DLSO Product

Nail Genesis DLSO Product (vehicle only)

FosmanogepixA Clinical Trial of the Study Medicine (Called Fosmanogepix) in Participants With Varying Degrees of Hepatic Function.

Recruiting

PHASE1

Sponsor:

Basilea Pharmaceutica

Location:

Rialto CA, Tampa FL

Code:

NCT05582187

Conditions

Hepatic Impairment

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

Fosmanogepix

VIR-2218 & VIR-3434Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434

Recruiting

PHASE1

Sponsor:

Vir Biotechnology, Inc.

Location:

Rialto CA, Tustin CA, Miami Lakes FL

Code:

NCT05484206

Conditions

Hepatic Impairment

Cirrhosis

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Accepted

Interventions

VIR-2218

VIR-3434

AZD5004Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD5004

Recruiting

PHASE1

Sponsor:

AstraZeneca

Location:

Rialto CA, Lake Forest CA, San Antonio TX, Orlando FL

Code:

NCT06813781

Conditions

Hepatic Impairment

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

AZD5004

MavorixaforA Study to Investigate Pharmacokinetics (PK) and Safety of a Single Dose of Mavorixafor in Participants With Hepatic Impairment (HI) Compared to Matched Healthy Volunteers With Normal Hepatic Function

Recruiting

PHASE1

Sponsor:

X4 Pharmaceuticals

Location:

Rialto CA, San Antonio TX

Code:

NCT06858696

Conditions

Hepatic Insufficiency

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

Mavorixafor